Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma

Marcella Willemsen, Darryl Tio, Gabrielle Krebbers, Fazira R. Kasiem, Elisabeth H. Jaspars, Tiago R. Matos, Marcel W. Bekkenk, Walbert J. Bakker, Rosalie M. Luiten

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)


The infiltration of tissue-resident memory (T RM) cells in melanoma correlates with improved survival, suggesting an important role for T RMcells in immunity against melanoma. However, little is known about the presence of T RMcells in nonmalignant and premalignant melanocytic lesions. This study aimed to evaluate the presence of T RMcells in human skin melanocytic lesions, representing the spectrum from healthy skin to metastatic melanoma. FFPE sections from healthy skin, sun-exposed skin, benign nevi, lentigo maligna (LM), primary LM melanoma, and primary cutaneous and metastatic melanoma were analyzed by immunohistochemistry. The number of infiltrating cells expressing T RM-associated markers, CD3, CD4, CD8, CD69, CD103, and CD49a, was quantified by digital analyses. Multiplex immunofluorescence was performed to analyze coexpression of T RMcell markers. More T cells and CD69 +cells were found in melanoma lesions, as compared with healthy skin and nevi. CD103 +and CD49a +cell numbers did not significantly differ. More importantly, no differences were seen in expression of all markers between healthy skin and benign nevi. Similar results, except for CD69, were observed in LM melanoma, as compared with LM and sun-exposed skin. Interestingly, multiplex immunofluorescence showed that nevi tissues have comparable CD103 +T cell numbers with healthy skin but comprise more CD103 +CD8 +cells. Expression of T RMcell markers is significantly increased in melanoma, as compared with nonmalignant skin. Our data also show that T RMcells are not abundantly present already in premalignant tissues. Further studies on the specificity of T RMcells for melanocyte/melanoma antigens may reveal their significance in cancer immunosurveillance.

Original languageEnglish
Pages (from-to)416-423
Number of pages8
JournalThe American Journal of Dermatopathology
Issue number6
Publication statusPublished - 1 Jun 2022


  • T cells
  • immunity
  • lentigo maligna
  • melanoma

Cite this